Patentanwalt / German Patent Attorney
European Patent Attorney
European Trademark and Design Attorney
Technical Expertise: Biochemistry, Pharmacology, Molecular Biology, Chemistry
Dr. Jörk Zwicker is partner with the firm Zwicker Schnappauf & Partner Patentanwälte PartG mbB. Jörk started his patent law career with one of Germany’s largest IP boutiques, continued to work as an associate in another large German IP boutique and then joined ZSP Patentanwälte Partg mbH to become a partner in 2006.
Jörk is admitted before the German Patent and Trademark Office, the German Federal Patent Court, the European Union Intellectual Property Office and the European Patent Office. He has successfully handled numerous patent applications, oppositions, nullity, and opinion matters, in particular in context of licensing procedures, in the fields of biochemistry, pharmacology, molecular biology, and chemistry on behalf of our national and international clients. Jörk is representing well known European, US, and Japanese companies.
Jörk studied chemistry at the Technical University Berlin (TU) and biology at the Massachusetts Institute of Technology (MIT), U.S.A. He obtained a Master’s of Chemistry (Dipl. Chem.) at the TU Berlin. He then started his Ph.D. work with Prof. Rolf Müller at the Institute of Molecular Biology and Tumor Research (IMT) at the Philipps-University Marburg. The Ph.D. was followed by postdoctoral research with Prof. Robert Tjian at the University of California, Berkeley, USA.
Jörk received fellowships of the “Studienstiftung des Deutschen Volkes”, the German-American Fulbright Commission, the “Boehringer Ingelheim Fonds, Foundation for Basic Research in Medicine”, the Howard Hughes Medical Institute, and an EMBO Postdoctoral fellowship.
Jörk is a member of several professional societies and participates in the working group “Life Sciences” of LES International.
Furthermore, Jörk is a lecturer at the pharmaceutical law degree program of the Philipps-University, Marburg and at the Hessen International Summer University (ISU) “Innovation and Regulation in Pharma & Medtech” at the Justus-Liebig-University, Gießen.